262 related articles for article (PubMed ID: 31163202)
1. Steroid receptor/coactivator binding inhibitors: An update.
Skowron KJ; Booker K; Cheng C; Creed S; David BP; Lazzara PR; Lian A; Siddiqui Z; Speltz TE; Moore TW
Mol Cell Endocrinol; 2019 Aug; 493():110471. PubMed ID: 31163202
[TBL] [Abstract][Full Text] [Related]
2. The conserved residues of the ligand-binding domains of steroid receptors are located in the core of the molecules.
Maeda M
J Mol Graph Model; 2001; 19(6):543-51, 601-6. PubMed ID: 11552682
[TBL] [Abstract][Full Text] [Related]
3. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.
He B; Wilson EM
Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084
[TBL] [Abstract][Full Text] [Related]
4. Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).
Moore TW; Mayne CG; Katzenellenbogen JA
Mol Endocrinol; 2010 Apr; 24(4):683-95. PubMed ID: 19933380
[TBL] [Abstract][Full Text] [Related]
5. Activation, transformation, and subunit structure of steroid hormone receptors.
Grody WW; Schrader WT; O'Malley BW
Endocr Rev; 1982; 3(2):141-63. PubMed ID: 7044769
[No Abstract] [Full Text] [Related]
6. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
[TBL] [Abstract][Full Text] [Related]
7. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription.
Smith CL; Oñate SA; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):8884-8. PubMed ID: 8799122
[TBL] [Abstract][Full Text] [Related]
8. The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors.
Edwards DP
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):307-24. PubMed ID: 14973393
[TBL] [Abstract][Full Text] [Related]
9. X-ray crystal structure of the ancestral 3-ketosteroid receptor-progesterone-mifepristone complex shows mifepristone bound at the coactivator binding interface.
Colucci JK; Ortlund EA
PLoS One; 2013; 8(11):e80761. PubMed ID: 24260475
[TBL] [Abstract][Full Text] [Related]
10. Membrane receptors for estrogen, progesterone, and testosterone in the rat brain: fantasy or reality.
Ramirez VD; Zheng J; Siddique KM
Cell Mol Neurobiol; 1996 Apr; 16(2):175-98. PubMed ID: 8743968
[TBL] [Abstract][Full Text] [Related]
11. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
[TBL] [Abstract][Full Text] [Related]
12. Dissection of androgen receptor-promoter interactions: steroid receptors partition their interaction energetics in parallel with their phylogenetic divergence.
De Angelis RW; Yang Q; Miura MT; Bain DL
J Mol Biol; 2013 Nov; 425(22):4223-35. PubMed ID: 23917122
[TBL] [Abstract][Full Text] [Related]
13. The activating enzyme of NEDD8 inhibits steroid receptor function.
Fan M; Long X; Bailey JA; Reed CA; Osborne E; Gize EA; Kirk EA; Bigsby RM; Nephew KP
Mol Endocrinol; 2002 Feb; 16(2):315-30. PubMed ID: 11818503
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of coregulator-induced conformational perturbations in androgen receptor ligand binding domain.
Zakharov MN; Pillai BK; Bhasin S; Ulloor J; Istomin AY; Guo C; Godzik A; Kumar R; Jasuja R
Mol Cell Endocrinol; 2011 Jul; 341(1-2):1-8. PubMed ID: 21605623
[TBL] [Abstract][Full Text] [Related]
15. Recognition and accommodation at the androgen receptor coactivator binding interface.
Hur E; Pfaff SJ; Payne ES; Grøn H; Buehrer BM; Fletterick RJ
PLoS Biol; 2004 Sep; 2(9):E274. PubMed ID: 15328534
[TBL] [Abstract][Full Text] [Related]
16. Alternative inhibition of androgen receptor signaling: peptidomimetic pyrimidines as direct androgen receptor/coactivator disruptors.
Gunther JR; Parent AA; Katzenellenbogen JA
ACS Chem Biol; 2009 Jun; 4(6):435-40. PubMed ID: 19441848
[TBL] [Abstract][Full Text] [Related]
17. Estrogen, progesterone, and androgen-binding sites in renal cell carcinoma. Observations obtained in Phase II trial of flutamide.
Ahmed T; Benedetto P; Yagoda A; Watson RC; Scher HI; Herr HW; Sogani PC; Whitmore WF; Pertschuk L
Cancer; 1984 Aug; 54(3):477-81. PubMed ID: 6733677
[TBL] [Abstract][Full Text] [Related]
18. Steroid receptors in the uterus: implications in endometriosis.
Moutsatsou P; Sekeris CE
Ann N Y Acad Sci; 2003 Nov; 997():209-22. PubMed ID: 14644828
[TBL] [Abstract][Full Text] [Related]
19. Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
Tamrazi A; Carlson KE; Rodriguez AL; Katzenellenbogen JA
Mol Endocrinol; 2005 Jun; 19(6):1516-28. PubMed ID: 15661830
[TBL] [Abstract][Full Text] [Related]
20. Sex steroid receptors in diverse human tumors.
Kobayashi S; Mizuno T; Tobioka N; Ichimura H; Samoto T; Tanaka H; Masaoka A; Wakabayashi S; Umemura S; Fukuoka H; Nagai H
Gan; 1982 Jun; 73(3):439-45. PubMed ID: 6290306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
